Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_1
1
13%
Ph phase_2
2
25%
Ph phase_3
5
63%

Phase Distribution

1

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
5(62.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (12.5%)
Phase 22 (25.0%)
Phase 35 (62.5%)

Trials by Status

completed8100%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

Dasotraline Pediatric ADHD Study

NCT02428088
completedphase_3

Dasotraline Binge Eating Disorder Extension Study

NCT02684279
completedphase_3

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

NCT03231800
completedphase_3

Dasotraline Pediatric Extension Study

NCT02457819
completedphase_2

Dasotraline Binge Eating Disorder Study

NCT02564588
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02428088Phase 2

Dasotraline Pediatric ADHD Study

Completed
NCT02684279Phase 3

Dasotraline Binge Eating Disorder Extension Study

Completed
NCT03231800Phase 3

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

Completed
NCT02457819Phase 3

Dasotraline Pediatric Extension Study

Completed
NCT02564588Phase 2

Dasotraline Binge Eating Disorder Study

Completed
NCT02276209Phase 3

Dasotraline Adult ADHD Study

Completed
NCT02160262Phase 3

Open-label Safety Study in Adults With ADHD

Completed
NCT02795637Phase 1

Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8